Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial
Annals of Hematology · 2024-06 · 103 (6) · 2133-2144
DOI: 10.1007/s00277-024-05757-1 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Hematology, online erschienen am 18.04.2024. Verfasst von Aishwarya Anand und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Hauptthemen laut MEDLINE: Warfarin, Cytochrome P-450 CYP2C9, International Normalized Ratio, Vitamin K Epoxide Reductases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
- Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Cardiothoracic and Vascular Surgery, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. deepesh.kem@gmail.com.
- Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Gastroenterology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Zitieren
APA
Anand, A., Hegde, N. C., Chhabra, P., Purohit, J., Kumar, R., Gupta, A., Lad, D. P., Mohindra, R., Mehrotra, S., Vijayvergiya, R., Kumar, B., Sharma, V., Malhotra, P., Ahluwalia, J., Das, R., Patil, A. N., Shafiq, N., & Malhotra, S. (2024). Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial. Annals of Hematology, 103(6), 2133-2144. https://doi.org/10.1007/s00277-024-05757-1
Vancouver
Anand A, Hegde NC, Chhabra P, Purohit J, Kumar R, Gupta A, et al. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial. Annals of Hematology. 2024;103(6):2133-2144. doi:10.1007/s00277-024-05757-1
BibTeX
@article{Anand2024,
author = {Anand, Aishwarya and Hegde, Naveen C and Chhabra, Pulkit and Purohit, Jai and Kumar, Rupesh and Gupta, Ankur and Lad, Deepesh P and Mohindra, Ritin and Mehrotra, Saurabh and Vijayvergiya, Rajesh and Kumar, Basant and Sharma, Vishal and Malhotra, Pankaj and Ahluwalia, Jasmina and Das, Reena and Patil, Amol N and Shafiq, Nusrat and Malhotra, Samir},
title = {Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial},
journal = {Annals of Hematology},
year = {2024},
volume = {103},
number = {6},
pages = {2133--2144},
doi = {10.1007/s00277-024-05757-1}
}
EUVIMED